Dissolution and permeation properties of naproxen from solid-state systems with chitosan

Drug Delivery

Volumn 15, Issue 5, 2008, Pages 303-312

  Corti, Giovanna ^a   Maestrelli, Francesca ^a   Cirri, Marzia ^a   Mura, Paola ^a   Zerrouk, Naima ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Artificial membrane; Caco 2 cells; Chitosan; Chitosan glutamate; Chitosan hydrochloride; Dissolution; Enhancer effect; Naproxen

Indexed keywords

CHITOSAN; CHITOSAN GLUTAMATE; DRUG CARRIER; NAPROXEN; POLYMER; SEACURE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLID STATE;

ADJUVANTS, PHARMACEUTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CALORIMETRY, DIFFERENTIAL SCANNING; CHITOSAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; MEMBRANES, ARTIFICIAL; NAPROXEN; PERMEABILITY; SOLUBILITY;

EID: 50849091600     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802006955     Document Type: Article

References (27)

1. Açikgoz, M., Kas, H. S., Hasçelik, Z., Milli, U., and Hincal, A. A. 1995. Chitosan microspheres of diclophenac sodium, II: in vitro and in vivo evaluation. Pharmazie 50:275-277.
2. Amidon, G. L., Lennernäs, H., Shah, V. P., and Crison, J. R. 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420.
3. Artursson, P., Palm, K., and Luthman, K. 2001. Caco-2 monolayers in experimental and theoretical prediction of drug transport. Adv. Drug. Del. Rev. 46:27-43.
4. Baldrick, P. 2000. Pharmaceutical excipient development: the need for preclinical guidance. Regul. Toxicol. Pharmacol. 32:210-218.
5. Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., and Mura, P. 2006a. Development and evaluation of an in vitro method for prediction of human drug absorption. I. Assessment of artificial membrane composition. Eur. J. Pharm. Sci. 27:346-353.
6. Corti, G., Maestrelli, F., Cirri, M., Zerrouk, N., and Mura, P. 2006b.Development and evaluation of an in vitro method for prediction of human drug absorption. II. Demonstration of the method suitability. Eur. J. Pharm. Sci. 27:354-362.
7. Dodane, V., Amin Khan, M., and Merwin, J. R. 1999. Effect of chitosan on epithelial permeability and structure.Int. J. Pharm. 182:21-32.
8. Felt, O., Buri, P., and Gurny, R. 1998. Chitosan: a unique polysaccharide for drug delivery.Drug Dev. Ind. Pharm. 24:979-993.
9. Genta, I., Perugini, P., Modena, T., Pavanetto, F., Castelli, F., Muzzarelli, R. A. A., Muzzarelli, C., and Conti, B. 2003. Miconazole-loaded 6-oxychitinchitosan microcapsules. Carbohydr. Polym. 52:11-18.
10. Gombar, V. K., Silver, I. S., and Zhao, Z. 2003. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability. Curr. Top. Med. Chem. 3:1205-1225.
11. Illum, L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1326-1331.
12. Kansy, M., Fisher, H., Kratzat, K., Senner, F., Wagner, B., and Parrilla, I. 2001. High-throughput artificial membrane permeability studies in early lead discovery and development: in Pharmacokinetic Optimization in Drug Research, eds. Testa, B., Van de Waterbeend, H., Folkers, G., and Guy, R., 447-464. Verlag Helvetica Chimica Acta, Weinheim, Germany, Wiley-VCH.
13. Khan, K. A. 1975. The concept of dissolution efficiency. J. Pharm. Pharmac. 27:48-49.
14. Kotzé, A. F., de Leeuw, B. J., Lueßen, H. L., de Boer, A. G., Verhoef, J .C., and Junginger, H. E. 1997. Chitosans for enhanced delivery of therapeutics peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers. Int. J. Pharm. 159:243-253.
15. Lobenberg, R., and Amidon, G. L. 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system, new scientific approaches to international regulatory standards. Eur. J. Pharm. Sci. 50:3-12.
16. Maestrelli, F., Zerrouk, N., Chemtob, C., and Mura, P. 2004. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 Cells. Int. J. Pharm. 271:257-267.
17. Mainprize, T., and Grady, L. T. 1998. Standardization of an in vitro method of drug absorption. Pharm. Forum 24:6015-6023.
18. Mishra, B., and Pandit, J. K. 1988. Comparative bioavailability of four naproxen tablets. Indian J. Pharm. Sci. 50:44-47.
19. Mura, P., Maestrelli, F., Cirri, M., Furlanetto, S., and Pinzauti, S. 2003a. Differential scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interactions. J. Therm. Anal. Calorim. 73:635-646.
20. Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F., and Chemtob, C. 2003b. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 19:67-75.
21. Nogami, H., Nagai, T., and Yotsuyanagi, I. 1969. Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull. 17:499-509.
22. Paul, W., and Sharma, C. P. 2000. Chitosan, a drug carrier for the 21th century. S.T.P. Pharm. Sci. 10:5-22.
23. Phillips, J., and Arena, A. 2003. Optimization of Caco-2 Cell Growth and Differentiation for Drug Transport Studies, Millipore Corporation Protocol Note PC1060EN00: Danvers, MA (USA).
24. Portero, A., Remuñan-Lopez, C., and Vila-Jato, J. L. 1998. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int. J. Pharm. 175:75-84.
25. Yamashita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., Sakane, H., and Tokuda, H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 10:195-204.
26. Zecchi, V., Rodriguez, L., Tartarini, A., Chiarini, A., and Valenti, P. 1984. In vitro absorption studies on naproxen and its sodium and piperazine salts. Pharm. Acta Helv. 59:91-94.
27. Zerrouk, N., Mennini, N., Maestrelli, F., Chemtob, C., and Mura, P. 2004. Comparison of the effect of chitosan and polyvynilpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 57:93-99.